pyridoxal phosphate has been researched along with Necrosis in 9 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Necrosis: The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Millart, H | 1 |
Alouane, L | 1 |
Oszust, F | 1 |
Chevallier, S | 1 |
Robinet, A | 1 |
Ni, Y | 1 |
Cresens, E | 1 |
Adriaens, P | 1 |
Dymarkowski, S | 1 |
Bogaert, J | 1 |
Zhang, H | 1 |
Bosmans, H | 1 |
Verbruggen, A | 1 |
Marchal, G | 1 |
Kandzari, DE | 1 |
Labinaz, M | 1 |
Cantor, WJ | 1 |
Madan, M | 1 |
Gallup, DS | 1 |
Hasselblad, V | 1 |
Joseph, D | 1 |
Allen, A | 1 |
Green, C | 1 |
Hidinger, KG | 1 |
Krucoff, MW | 1 |
Christenson, RH | 1 |
Harrington, RA | 1 |
Tcheng, JE | 1 |
Uspenskaya, YA | 1 |
Mikhutkina, SV | 1 |
Taksanova, EI | 1 |
Popova, NN | 1 |
Olovyannikova, RY | 1 |
Salmina, AB | 1 |
Friedman, HI | 1 |
De Venuto, F | 1 |
Schwartz, BD | 1 |
Nemeth, TJ | 1 |
Chezmar, JL | 1 |
Redvanly, RD | 1 |
Sewell, CW | 1 |
Yamashima, T | 1 |
Zhao, L | 1 |
Wang, XD | 1 |
Tsukada, T | 1 |
Tonchev, AB | 1 |
Rossouw, JE | 1 |
Labadarios, D | 1 |
Davis, M | 1 |
Williams, R | 1 |
Olbrich, HG | 1 |
Boeker, JF | 1 |
Rachor, S | 1 |
Ketelsen, UP | 1 |
Wieland, H | 1 |
Kober, G | 1 |
Schmidt, A | 1 |
Mutschler, E | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
MEND-CABG II: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG Surgery[NCT00402506] | Phase 3 | 3,000 participants (Anticipated) | Interventional | 2006-11-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for pyridoxal phosphate and Necrosis
Article | Year |
---|---|
Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial).
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiotonic Agents; Coronary Angiography; Coronary Disease; Do | 2003 |
Uptake of mangafodipir trisodium (MnDPDP) by hepatocellular carcinoma: correlation with unenhanced imaging findings and histopathologic features.
Topics: Adult; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Humans; Image Enhancement; Li | 1996 |
7 other studies available for pyridoxal phosphate and Necrosis
Article | Year |
---|---|
Involvement of P2Y receptors in pyridoxal-5'-phosphate-induced cardiac preconditioning.
Topics: Animals; Creatine Kinase; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Male; Myocar | 2009 |
Exploring multifunctional features of necrosis avid contrast agents.
Topics: Animals; Contrast Media; Edetic Acid; Gadolinium DTPA; Half-Life; Liver Diseases; Liver Neoplasms; M | 2002 |
Induction of apoptosis in bone marrow cells is mediated via purinergic receptors.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Bone Marrow Cells; Doxorubicin; Male; Mice; Necrosis; Py | 2004 |
In vivo evaluation of pyridoxalated-polymerized hemoglobin solution.
Topics: Animals; Blood Pressure; Blood Transfusion; Evaluation Studies as Topic; Half-Life; Hemoglobins; Kid | 1984 |
Neuroprotective effects of pyridoxal phosphate and pyridoxal against ischemia in monkeys.
Topics: Animals; Brain Ischemia; Cathepsin B; Cathepsin L; Cathepsins; Cell Death; Cysteine Endopeptidases; | 2001 |
Vitamin B6 and aspartate aminotransferase activity in chronic liver disease.
Topics: Aspartate Aminotransferases; Chronic Disease; Humans; Liver Cirrhosis; Liver Diseases; Necrosis; Pyr | 1978 |
Effect of magnesium pyridoxal 5-phosphate glutamate on the hamster cardiomyopathy.
Topics: Animals; Calcium; Calcium Channel Blockers; Cardiomyopathies; Cricetinae; Lipid Metabolism; Lipids; | 1992 |